Drug profile · INN
acoramidis
BEYONTTRA
acoramidis (BEYONTTRA) is a transthyretin stabiliser.
EMA: approved Cardiovascular system (C01) C01EB25
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — acoramidis
- Class
- Cardiovascular system (C01)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
acoramidis (BEYONTTRA) is a transthyretin stabiliser.
Key facts
INN acoramidis
Brand BEYONTTRA
Mechanism Transthyretin stabiliser
Target Transthyretin
Therapeutic class Cardiovascular system (C01)
ATC code C01EB25
Mechanism of action
Transthyretin stabiliser
Primary target: Transthyretin
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is acoramidis?
acoramidis (BEYONTTRA) is a transthyretin stabiliser.
What is the brand name for acoramidis?
BEYONTTRA is a marketed brand name for acoramidis. Check FDA Drugs@FDA for the current US label holder and prescribing information.